We are live on ! Find out more
CNHF

Conrad N. Hilton Foundation Portfolio holdings

AUM $228M
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
+26.89%
1 Year Est. Return
+15.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.85M
AUM Growth
-$72.2M
Cap. Flow
-$71.7M
Cap. Flow %
-913.79%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
Reduced
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
1
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7.85M 100%
+63,481
New +$8.34M
IEFA icon
2
iShares Core MSCI EAFE ETF
IEFA
$187B
-828,587
Closed -$49.9M
IVV icon
3
iShares Core S&P 500 ETF
IVV
$869B
-15,069
Closed -$5.06M
VNQ icon
4
Vanguard Real Estate ETF
VNQ
$40.2B
-317,078
Closed -$25M

Similar funds

Conrad N. Hilton Foundation's Q4 2020 Portfolio in Review

As of Q4 2020, Conrad N. Hilton Foundation held 4 positions worth $7.85M, down 90% from $80M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Conrad N. Hilton Foundation withdrew a net $71.7M in Q4 2020, closing 3 positions. Its most notable exit was iShares Core MSCI EAFE ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

Against the trend, Conrad N. Hilton Foundation opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $7.85M.

  • Conrad N. Hilton Foundation's largest Q4 2020 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 63,481 shares worth $7.85M.
  • Conrad N. Hilton Foundation fully exited iShares Core MSCI EAFE ETF in Q4 2020, selling an estimated $49.9M.
  • Conrad N. Hilton Foundation's ten largest holdings make up 100% of its $7.85M portfolio in Q4 2020.
  • Conrad N. Hilton Foundation opened 1 new position and closed 3 in Q4 2020.
  • Conrad N. Hilton Foundation's portfolio value fell 90% quarter-over-quarter to $7.85M.

Based on Conrad N. Hilton Foundation's 13F filing for Q4 2020, filed 16 Feb 2021.